Investigation of Metabolomics Differences Between Metabolic Syndrome and Healthy Individuals in Taiwan

N/ANot Yet RecruitingNCT06363864

Leeuwenhoek Laboratories Co. Ltd.1,200 enrolled

Overview

The prevalence of metabolic syndrome in Taiwan has been increasing yearly. In this project, the database of blood test results from healthy and metabolic syndromes individuals will be analyzed to identify the small molecules related to the severity of metabolic syndrome. These identified small molecules could be used as biomarkers to predict the development of metabolic syndromes in the future.

Study Type

OBSERVATIONAL

Enrollment

1,200

Conditions

Metabolic Syndrome

Eligibility

Sex: ALLMin age: 20 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Capable adults weigh ≥ 50 kg Exclusion Criteria: * Not Taiwanese * Having received oral antibiotics, immunosuppressants, and chemotherapy drugs in the past month * Incapacity * Limited disposing capacity * Mental disorders or intellectual disabilities

Outcomes

Primary Outcomes

Concentration changes of small molecules in blood.

Concentrations of small molecules in healthy individuals and metabolic syndrom patients will be analyzed to identify specific biomarkers for metabolic syndrome.

Time frame: Up to six years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.